Efficacy and safety of COVID‐19 vaccines

BACKGROUND: Different forms of vaccines have been developed to prevent the SARS‐CoV‐2 virus and subsequent COVID‐19 disease. Several are in widespread use globally.  OBJECTIVES: To assess the efficacy and safety of COVID‐19 vaccines (as a full primary vaccination series or a booster dose) against SA...

Descripción completa

Detalles Bibliográficos
Autores principales: Graña, Carolina, Ghosn, Lina, Evrenoglou, Theodoros, Jarde, Alexander, Minozzi, Silvia, Bergman, Hanna, Buckley, Brian S, Probyn, Katrin, Villanueva, Gemma, Henschke, Nicholas, Bonnet, Hillary, Assi, Rouba, Menon, Sonia, Marti, Melanie, Devane, Declan, Mallon, Patrick, Lelievre, Jean-Daniel, Askie, Lisa M, Kredo, Tamara, Ferrand, Gabriel, Davidson, Mauricia, Riveros, Carolina, Tovey, David, Meerpohl, Joerg J, Grasselli, Giacomo, Rada, Gabriel, Hróbjartsson, Asbjørn, Ravaud, Philippe, Chaimani, Anna, Boutron, Isabelle
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Ltd 2022
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9726273/
https://www.ncbi.nlm.nih.gov/pubmed/36473651
http://dx.doi.org/10.1002/14651858.CD015477

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9726273/
https://www.ncbi.nlm.nih.gov/pubmed/36473651
http://dx.doi.org/10.1002/14651858.CD015477

Ejemplares similares